Skip to main content
Top
Published in: High Blood Pressure & Cardiovascular Prevention 1/2022

01-01-2022 | COVID-19 | Review article

Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic

Authors: Barbara Citoni, Ilaria Figliuzzi, Vivianne Presta, Massimo Volpe, Giuliano Tocci

Published in: High Blood Pressure & Cardiovascular Prevention | Issue 1/2022

Login to get access

Abstract

Hypertension is the most common cardiovascular risk factor for acute cardiovascular outcomes, including acute coronary disease, stroke, chronic kidney disease and congestive heart failure. Despite the fact that it represents the most prevalent risk factor in the general population, mostly in elderly individuals, its awareness is still relatively low, being about one third of patients living with undiagnosed hypertension and high risk of experiencing acute cardiovascular events. In addition, though recent improvement in pharmacological and non-pharmacological therapeutic options, hypertension is largely uncontrolled, with about 35–40% of treated hypertensive patients achieving the recommended therapeutic targets. Among different modern interventions proposed for improving blood pressure control in treated hypertensive patients, a systematic adoption of home BP monitoring has demonstrated to be one of the most effective. Indeed, it improves patients’ awareness of the disease and adherence to prescribed medications and allows tailoring and personalizing BP lowering therapies. Home BP monitoring is particularly suitable for telemedicine and mobile-health solutions. Indeed, in specific conditions, when face-to-face interactions between patients and physicians are not allowed or even suspended, as in case of COVID-19 pandemic, telemedicine may ensure effective management of hypertension, as well as other cardiovascular and non-cardiovascular comorbidities. This review will summarize strengths and limitations of telemedicine in the clinical management of hypertension with a particular focus on the lessons learned during the COVID-19 pandemic.
Literature
1.
go back to reference Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.PubMedPubMedCentralCrossRef Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.PubMedPubMedCentralCrossRef
2.
go back to reference Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.PubMedCrossRef Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.PubMedCrossRef
3.
go back to reference Tocci G, Nati G, Cricelli C, Parretti D, Lapi F, Ferrucci A, et al. Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database. J Hum Hypertens. 2017;31(4):258–62.PubMedCrossRef Tocci G, Nati G, Cricelli C, Parretti D, Lapi F, Ferrucci A, et al. Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database. J Hum Hypertens. 2017;31(4):258–62.PubMedCrossRef
4.
go back to reference Tocci G, Ferrucci A, Pontremoli R, Ferri C, Rosei EA, Morganti A, et al. Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000–2005 and 2005–2011 hypertension surveys. J Hum Hypertens. 2015;29(11):696–701.PubMedCrossRef Tocci G, Ferrucci A, Pontremoli R, Ferri C, Rosei EA, Morganti A, et al. Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000–2005 and 2005–2011 hypertension surveys. J Hum Hypertens. 2015;29(11):696–701.PubMedCrossRef
5.
go back to reference Tocci G, Presta V, Ferri C, Redon J, Volpe M. Blood Pressure Targets Achievement According to 2018 ESC/ESH Guidelines in Three European Excellence Centers for Hypertension. High Blood Press Cardiovasc Prev. 2020;27(1):51–9.PubMedCrossRef Tocci G, Presta V, Ferri C, Redon J, Volpe M. Blood Pressure Targets Achievement According to 2018 ESC/ESH Guidelines in Three European Excellence Centers for Hypertension. High Blood Press Cardiovasc Prev. 2020;27(1):51–9.PubMedCrossRef
6.
go back to reference Tocci G, Presta V, Citoni B, Figliuzzi I, Bianchi F, Ferrucci A, et al. Blood pressure target achievement under monotheraphy: a real-life appraisal. High Blood Press Cardiovasc Prev. 2020;27(6):587–96.PubMedPubMedCentralCrossRef Tocci G, Presta V, Citoni B, Figliuzzi I, Bianchi F, Ferrucci A, et al. Blood pressure target achievement under monotheraphy: a real-life appraisal. High Blood Press Cardiovasc Prev. 2020;27(6):587–96.PubMedPubMedCentralCrossRef
7.
go back to reference Mancia G, Pessina AC, Trimarco B, Grassi G, Group SSILsVdIAnS. Blood pressure control according to new guidelines targets in low- to high-risk hypertensives managed in specialist practice. J Hypertens. 2004;22(12):2387–96.PubMedCrossRef Mancia G, Pessina AC, Trimarco B, Grassi G, Group SSILsVdIAnS. Blood pressure control according to new guidelines targets in low- to high-risk hypertensives managed in specialist practice. J Hypertens. 2004;22(12):2387–96.PubMedCrossRef
8.
go back to reference Redon J, Mourad JJ, Schmieder RE, Volpe M, Weiss TW. Why in 2016 are patients with hypertension not 100% controlled? A call to action J Hypertens. 2016;34(8):1480–8. Redon J, Mourad JJ, Schmieder RE, Volpe M, Weiss TW. Why in 2016 are patients with hypertension not 100% controlled? A call to action J Hypertens. 2016;34(8):1480–8.
9.
go back to reference Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.PubMedCrossRef Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.PubMedCrossRef
10.
go back to reference Volpe M, Rosei EA, Ambrosioni E, Cottone S, Cuspidi C, Borghi C, et al. 2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. High Blood Press Cardiovasc Prev. 2013;20(1):45–52.PubMedCrossRef Volpe M, Rosei EA, Ambrosioni E, Cottone S, Cuspidi C, Borghi C, et al. 2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. High Blood Press Cardiovasc Prev. 2013;20(1):45–52.PubMedCrossRef
11.
go back to reference Breaux-Shropshire TL, Judd E, Vucovich LA, Shropshire TS, Singh S. Does home blood pressure monitoring improve patient outcomes? A systematic review comparing home and ambulatory blood pressure monitoring on blood pressure control and patient outcomes. Integr Blood Press Control. 2015;8:43–9.PubMedPubMedCentralCrossRef Breaux-Shropshire TL, Judd E, Vucovich LA, Shropshire TS, Singh S. Does home blood pressure monitoring improve patient outcomes? A systematic review comparing home and ambulatory blood pressure monitoring on blood pressure control and patient outcomes. Integr Blood Press Control. 2015;8:43–9.PubMedPubMedCentralCrossRef
12.
go back to reference Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.PubMedCrossRef Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.PubMedCrossRef
13.
go back to reference Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.PubMedPubMedCentralCrossRef Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.PubMedPubMedCentralCrossRef
14.
go back to reference Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2001227.PubMedPubMedCentralCrossRef Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2001227.PubMedPubMedCentralCrossRef
15.
go back to reference Wang X, Fang J, Zhu Y, Chen L, Ding F, Zhou R, et al. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital. Clin Microbiol Infect. 2020;26(8):1063–8.PubMedPubMedCentralCrossRef Wang X, Fang J, Zhu Y, Chen L, Ding F, Zhou R, et al. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital. Clin Microbiol Infect. 2020;26(8):1063–8.PubMedPubMedCentralCrossRef
16.
go back to reference Giannouchos TV, Biskupiak J, Moss MJ, Brixner D, Andreyeva E, Ukert B. Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital system. Am J Emerg Med. 2021;40:20–6.PubMedCrossRef Giannouchos TV, Biskupiak J, Moss MJ, Brixner D, Andreyeva E, Ukert B. Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital system. Am J Emerg Med. 2021;40:20–6.PubMedCrossRef
17.
go back to reference Singh AK, Gillies CL, Singh R, Singh A, Chudasama Y, Coles B, et al. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. Diabetes Obes Metab. 2020;22(10):1915–24.PubMedCrossRef Singh AK, Gillies CL, Singh R, Singh A, Chudasama Y, Coles B, et al. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. Diabetes Obes Metab. 2020;22(10):1915–24.PubMedCrossRef
18.
go back to reference Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-angiotensin-aldosterone system blockers and the risk of Covid-19. N Engl J Med. 2020;382(25):2431–40.PubMedCrossRef Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-angiotensin-aldosterone system blockers and the risk of Covid-19. N Engl J Med. 2020;382(25):2431–40.PubMedCrossRef
19.
go back to reference Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. 2020;382(25):2441–8.PubMedCrossRef Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. 2020;382(25):2441–8.PubMedCrossRef
20.
go back to reference Wang Z, Zhang D, Wang S, Jin Y, Huan J, Wu Y, et al. A retrospective study from 2 centers in china on the effects of continued use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with hypertension and COVID-19. Med Sci Monit. 2020;26:e926651.PubMedPubMedCentral Wang Z, Zhang D, Wang S, Jin Y, Huan J, Wu Y, et al. A retrospective study from 2 centers in china on the effects of continued use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with hypertension and COVID-19. Med Sci Monit. 2020;26:e926651.PubMedPubMedCentral
21.
go back to reference Iaccarino G, Borghi C, Cicero AFG, Ferri C, Minuz P, Muiesan ML, et al. Renin-angiotensin system inhibition in cardiovascular patients at the time of COVID19: much ado for nothing? A statement of activity from the directors of the board and the scientific directors of the italian society of hypertension. High Blood Press Cardiovasc Prev. 2020;27(2):105–8.PubMedPubMedCentralCrossRef Iaccarino G, Borghi C, Cicero AFG, Ferri C, Minuz P, Muiesan ML, et al. Renin-angiotensin system inhibition in cardiovascular patients at the time of COVID19: much ado for nothing? A statement of activity from the directors of the board and the scientific directors of the italian society of hypertension. High Blood Press Cardiovasc Prev. 2020;27(2):105–8.PubMedPubMedCentralCrossRef
22.
go back to reference Omboni S, Ferrari R. The role of telemedicine in hypertension management: focus on blood pressure telemonitoring. Curr Hypertens Rep. 2015;17(4):535.PubMedCrossRef Omboni S, Ferrari R. The role of telemedicine in hypertension management: focus on blood pressure telemonitoring. Curr Hypertens Rep. 2015;17(4):535.PubMedCrossRef
23.
go back to reference Omboni S, Panzeri E, Campolo L. E-health in hypertension management: an insight into the current and future role of blood pressure telemonitoring. Curr Hypertens Rep. 2020;22(6):42.PubMedCrossRef Omboni S, Panzeri E, Campolo L. E-health in hypertension management: an insight into the current and future role of blood pressure telemonitoring. Curr Hypertens Rep. 2020;22(6):42.PubMedCrossRef
24.
go back to reference Piotrowicz E, Piepoli MF, Jaarsma T, Lambrinou E, Coats AJ, Schmid JP, et al. Telerehabilitation in heart failure patients: the evidence and the pitfalls. Int J Cardiol. 2016;220:408–13.PubMedCrossRef Piotrowicz E, Piepoli MF, Jaarsma T, Lambrinou E, Coats AJ, Schmid JP, et al. Telerehabilitation in heart failure patients: the evidence and the pitfalls. Int J Cardiol. 2016;220:408–13.PubMedCrossRef
25.
go back to reference Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Winkler S, et al. Telemedical Interventional Management in Heart Failure II (TIM-HF2), a randomised, controlled trial investigating the impact of telemedicine on unplanned cardiovascular hospitalisations and mortality in heart failure patients: study design and description of the intervention. Eur J Heart Fail. 2018;20(10):1485–93.PubMedCrossRef Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Winkler S, et al. Telemedical Interventional Management in Heart Failure II (TIM-HF2), a randomised, controlled trial investigating the impact of telemedicine on unplanned cardiovascular hospitalisations and mortality in heart failure patients: study design and description of the intervention. Eur J Heart Fail. 2018;20(10):1485–93.PubMedCrossRef
26.
go back to reference Spencker S, Coban N, Koch L, Schirdewan A, Müller D. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace. 2009;11(4):483–8.PubMedCrossRef Spencker S, Coban N, Koch L, Schirdewan A, Müller D. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace. 2009;11(4):483–8.PubMedCrossRef
27.
go back to reference Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med. 2019;381(20):1909–17.PubMedPubMedCentralCrossRef Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med. 2019;381(20):1909–17.PubMedPubMedCentralCrossRef
28.
go back to reference Parati G, Omboni S, Palatini P, Rizzoni D, Bilo G, Valentini M, et al. Italian society of hypertension guidelines for conventional and automated blood pressure measurement in the office, at home and over 24 hours. High Blood Press Cardiovasc Prev. 2008;15(4):283–310.PubMedCrossRef Parati G, Omboni S, Palatini P, Rizzoni D, Bilo G, Valentini M, et al. Italian society of hypertension guidelines for conventional and automated blood pressure measurement in the office, at home and over 24 hours. High Blood Press Cardiovasc Prev. 2008;15(4):283–310.PubMedCrossRef
29.
go back to reference Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010;24(12):779–85.PubMedCrossRef Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010;24(12):779–85.PubMedCrossRef
30.
go back to reference Omboni S, Caserini M, Coronetti C. Telemedicine and M-health in hypertension management: technologies, applications and clinical evidence. High Blood Press Cardiovasc Prev. 2016;23(3):187–96.PubMedCrossRef Omboni S, Caserini M, Coronetti C. Telemedicine and M-health in hypertension management: technologies, applications and clinical evidence. High Blood Press Cardiovasc Prev. 2016;23(3):187–96.PubMedCrossRef
31.
go back to reference Omboni S, McManus RJ, Bosworth HB, Chappell LC, Green BB, Kario K, et al. Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: an international expert position paper. Hypertension. 2020;76(5):1368–83.PubMedCrossRef Omboni S, McManus RJ, Bosworth HB, Chappell LC, Green BB, Kario K, et al. Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: an international expert position paper. Hypertension. 2020;76(5):1368–83.PubMedCrossRef
32.
go back to reference Mulè G, Caimi G, Cottone S, Nardi E, Andronico G, Piazza G, et al. Value of home blood pressures as predictor of target organ damage in mild arterial hypertension. J Cardiovasc Risk. 2002;9(2):123–9.PubMedCrossRef Mulè G, Caimi G, Cottone S, Nardi E, Andronico G, Piazza G, et al. Value of home blood pressures as predictor of target organ damage in mild arterial hypertension. J Cardiovasc Risk. 2002;9(2):123–9.PubMedCrossRef
33.
go back to reference Burke LE, Styn MA, Sereika SM, Conroy MB, Ye L, Glanz K, et al. Using mHealth technology to enhance self-monitoring for weight loss: a randomized trial. Am J Prev Med. 2012;43(1):20–6.PubMedPubMedCentralCrossRef Burke LE, Styn MA, Sereika SM, Conroy MB, Ye L, Glanz K, et al. Using mHealth technology to enhance self-monitoring for weight loss: a randomized trial. Am J Prev Med. 2012;43(1):20–6.PubMedPubMedCentralCrossRef
34.
go back to reference Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.PubMedCrossRef Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.PubMedCrossRef
35.
go back to reference Stergiou GS, Argyraki KK, Moyssakis I, Mastorantonakis SE, Achimastos AD, Karamanos VG, et al. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension. Am J Hypertens. 2007;20(6):616–21.PubMedCrossRef Stergiou GS, Argyraki KK, Moyssakis I, Mastorantonakis SE, Achimastos AD, Karamanos VG, et al. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension. Am J Hypertens. 2007;20(6):616–21.PubMedCrossRef
36.
go back to reference Hoshide S, Yano Y, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, et al. Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese general practice population: the japan morning surge-home blood pressure study. Hypertension. 2016;68(1):54–61.PubMedCrossRef Hoshide S, Yano Y, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, et al. Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese general practice population: the japan morning surge-home blood pressure study. Hypertension. 2016;68(1):54–61.PubMedCrossRef
37.
go back to reference Hoshide S, Yano Y, Mizuno H, Kanegae H, Kario K. Day-by-day variability of home blood pressure and incident cardiovascular disease in clinical practice: the J-HOP Study (Japan Morning Surge-Home Blood Pressure). Hypertension. 2018;71(1):177–84.PubMedCrossRef Hoshide S, Yano Y, Mizuno H, Kanegae H, Kario K. Day-by-day variability of home blood pressure and incident cardiovascular disease in clinical practice: the J-HOP Study (Japan Morning Surge-Home Blood Pressure). Hypertension. 2018;71(1):177–84.PubMedCrossRef
38.
go back to reference Postel-Vinay N, Steichen O, Pébelier E, Persu A, Berra E, Bobrie G, et al. Home blood pressure monitoring and e-Health: investigation of patients’ experience with the Hy-Result system. Blood Press Monit. 2020;25(3):155–61.PubMedCrossRef Postel-Vinay N, Steichen O, Pébelier E, Persu A, Berra E, Bobrie G, et al. Home blood pressure monitoring and e-Health: investigation of patients’ experience with the Hy-Result system. Blood Press Monit. 2020;25(3):155–61.PubMedCrossRef
39.
go back to reference Zhu H, Liang X, Pan XF, Huang C, Kuang J, Lv W, et al. A prospective cohort study of home blood pressure monitoring based on an intelligent cloud platform (the HBPM-iCloud study): rationale and design. Ther Adv Chronic Dis. 2020;11:2040622320933108.PubMedPubMedCentralCrossRef Zhu H, Liang X, Pan XF, Huang C, Kuang J, Lv W, et al. A prospective cohort study of home blood pressure monitoring based on an intelligent cloud platform (the HBPM-iCloud study): rationale and design. Ther Adv Chronic Dis. 2020;11:2040622320933108.PubMedPubMedCentralCrossRef
40.
go back to reference Kim YN, Shin DG, Park S, Lee CH. Randomized clinical trial to assess the effectiveness of remote patient monitoring and physician care in reducing office blood pressure. Hypertens Res. 2015;38(7):491–7.PubMedCrossRef Kim YN, Shin DG, Park S, Lee CH. Randomized clinical trial to assess the effectiveness of remote patient monitoring and physician care in reducing office blood pressure. Hypertens Res. 2015;38(7):491–7.PubMedCrossRef
41.
go back to reference Parati G, Omboni S, Albini F, Piantoni L, Giuliano A, Revera M, et al. Home blood pressure telemonitoring improves hypertension control in general practice. The TeleBPCare study. J Hypertens. 2009;27(1):198–203.PubMedCrossRef Parati G, Omboni S, Albini F, Piantoni L, Giuliano A, Revera M, et al. Home blood pressure telemonitoring improves hypertension control in general practice. The TeleBPCare study. J Hypertens. 2009;27(1):198–203.PubMedCrossRef
42.
go back to reference McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010;376(9736):163–72.PubMedCrossRef McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010;376(9736):163–72.PubMedCrossRef
43.
go back to reference Cuffee YL, Sciamanna C, Gerin W, Lehman E, Cover L, Johnson AA, et al. The effectiveness of home blood pressure on 24-hour blood pressure control: a randomized controlled trial. Am J Hypertens. 2019;32(2):186–92.PubMedCrossRef Cuffee YL, Sciamanna C, Gerin W, Lehman E, Cover L, Johnson AA, et al. The effectiveness of home blood pressure on 24-hour blood pressure control: a randomized controlled trial. Am J Hypertens. 2019;32(2):186–92.PubMedCrossRef
44.
go back to reference Mokwatsi GG, Hoshide S, Kanegae H, Fujiwara T, Negishi K, Schutte AE, et al. Direct comparison of home versus ambulatory defined nocturnal hypertension for predicting cardiovascular events: the Japan morning surge-home blood pressure (J-HOP) study. Hypertension. 2020;76(2):554–61.PubMedCrossRef Mokwatsi GG, Hoshide S, Kanegae H, Fujiwara T, Negishi K, Schutte AE, et al. Direct comparison of home versus ambulatory defined nocturnal hypertension for predicting cardiovascular events: the Japan morning surge-home blood pressure (J-HOP) study. Hypertension. 2020;76(2):554–61.PubMedCrossRef
45.
go back to reference Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013;31(3):455–67 (discussion 67–8).PubMedCrossRef Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013;31(3):455–67 (discussion 67–8).PubMedCrossRef
46.
go back to reference Tamura Y, Takeyasu R, Furukawa A, Takada H, Takechi M, Taniguchi H, et al. How COVID-19 affected the introduction of telemedicine and patient reported outcomes among patients with pulmonary hypertension—a report from a referral center in Japan. Circ Rep. 2020;2(9):526–30.PubMedPubMedCentralCrossRef Tamura Y, Takeyasu R, Furukawa A, Takada H, Takechi M, Taniguchi H, et al. How COVID-19 affected the introduction of telemedicine and patient reported outcomes among patients with pulmonary hypertension—a report from a referral center in Japan. Circ Rep. 2020;2(9):526–30.PubMedPubMedCentralCrossRef
47.
go back to reference Tersalvi G, Winterton D, Cioffi GM, Ghidini S, Roberto M, Biasco L, et al. Telemedicine in heart failure during COVID-19: a step into the future. Front Cardiovasc Med. 2020;7:612818.PubMedPubMedCentralCrossRef Tersalvi G, Winterton D, Cioffi GM, Ghidini S, Roberto M, Biasco L, et al. Telemedicine in heart failure during COVID-19: a step into the future. Front Cardiovasc Med. 2020;7:612818.PubMedPubMedCentralCrossRef
48.
go back to reference Salzano A, D’Assante R, Stagnaro FM, Valente V, Crisci G, Giardino F, et al. Heart failure management during the COVID-19 outbreak in Italy: a telemedicine experience from a heart failure university tertiary referral centre. Eur J Heart Fail. 2020;22(6):1048–50.PubMedCrossRef Salzano A, D’Assante R, Stagnaro FM, Valente V, Crisci G, Giardino F, et al. Heart failure management during the COVID-19 outbreak in Italy: a telemedicine experience from a heart failure university tertiary referral centre. Eur J Heart Fail. 2020;22(6):1048–50.PubMedCrossRef
49.
go back to reference Hjorth-Hansen AK, Andersen GN, Graven T, Gundersen GH, Kleinau JO, Mjølstad OC, et al. Feasibility and accuracy of tele-echocardiography, with examinations by nurses and interpretation by an expert via telemedicine, in an outpatient heart failure clinic. J Ultrasound Med. 2020;39(12):2313–23.PubMedCrossRef Hjorth-Hansen AK, Andersen GN, Graven T, Gundersen GH, Kleinau JO, Mjølstad OC, et al. Feasibility and accuracy of tele-echocardiography, with examinations by nurses and interpretation by an expert via telemedicine, in an outpatient heart failure clinic. J Ultrasound Med. 2020;39(12):2313–23.PubMedCrossRef
50.
go back to reference Easom AM, Shukla AM, Rotaru D, Ounpraseuth S, Shah SV, Arthur JM, et al. Home run-results of a chronic kidney disease Telemedicine Patient Education Study. Clin Kidney J. 2020;13(5):867–72.PubMedCrossRef Easom AM, Shukla AM, Rotaru D, Ounpraseuth S, Shah SV, Arthur JM, et al. Home run-results of a chronic kidney disease Telemedicine Patient Education Study. Clin Kidney J. 2020;13(5):867–72.PubMedCrossRef
51.
go back to reference Crispo A, Montagnese C, Perri F, Grimaldi M, Bimonte S, Augustin LS, et al. COVID-19 emergency and post-emergency in italian cancer patients: how can patients be assisted? Front Oncol. 2020;10:1571.PubMedPubMedCentralCrossRef Crispo A, Montagnese C, Perri F, Grimaldi M, Bimonte S, Augustin LS, et al. COVID-19 emergency and post-emergency in italian cancer patients: how can patients be assisted? Front Oncol. 2020;10:1571.PubMedPubMedCentralCrossRef
52.
go back to reference Rossi B, Zoccali C, Baldi J, Scotto di Uccio A, Biagini R, De Luca A, et al. Reorganization tips from a sarcoma unit at time of the COVID-19 pandemic in Italy: early experience from a regional referral oncologic center. J Clin Med. 2020;9(6):1868.PubMedCentralCrossRef Rossi B, Zoccali C, Baldi J, Scotto di Uccio A, Biagini R, De Luca A, et al. Reorganization tips from a sarcoma unit at time of the COVID-19 pandemic in Italy: early experience from a regional referral oncologic center. J Clin Med. 2020;9(6):1868.PubMedCentralCrossRef
53.
go back to reference Parati G, Omboni S, Compare A, Grossi E, Callus E, Venco A, et al. Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determinants of adherence (TELEBPMET Study). Trials. 2013;14:22.PubMedPubMedCentralCrossRef Parati G, Omboni S, Compare A, Grossi E, Callus E, Venco A, et al. Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determinants of adherence (TELEBPMET Study). Trials. 2013;14:22.PubMedPubMedCentralCrossRef
54.
go back to reference Omboni S, Mancinelli A, Rizzi F, Parati G, Group TTobPiLpP. Telemonitoring of 24-hour blood pressure in local pharmacies and blood pressure control in the community: the templar project. Am J Hypertens. 2019;32(7):629–39.PubMedCrossRef Omboni S, Mancinelli A, Rizzi F, Parati G, Group TTobPiLpP. Telemonitoring of 24-hour blood pressure in local pharmacies and blood pressure control in the community: the templar project. Am J Hypertens. 2019;32(7):629–39.PubMedCrossRef
55.
go back to reference Kaambwa B, Bryan S, Jowett S, Mant J, Bray EP, Hobbs FD, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis. Eur J Prev Cardiol. 2014;21(12):1517–30.PubMedCrossRef Kaambwa B, Bryan S, Jowett S, Mant J, Bray EP, Hobbs FD, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis. Eur J Prev Cardiol. 2014;21(12):1517–30.PubMedCrossRef
56.
go back to reference McKinstry B, Hanley J, Wild S, Pagliari C, Paterson M, Lewis S, et al. Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial. BMJ. 2013;346:f3030.PubMedPubMedCentralCrossRef McKinstry B, Hanley J, Wild S, Pagliari C, Paterson M, Lewis S, et al. Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial. BMJ. 2013;346:f3030.PubMedPubMedCentralCrossRef
57.
go back to reference Stoddart A, Hanley J, Wild S, Pagliari C, Paterson M, Lewis S, et al. Telemonitoring-based service redesign for the management of uncontrolled hypertension (HITS): cost and cost-effectiveness analysis of a randomised controlled trial. BMJ Open. 2013;3(5):e002681.PubMedPubMedCentralCrossRef Stoddart A, Hanley J, Wild S, Pagliari C, Paterson M, Lewis S, et al. Telemonitoring-based service redesign for the management of uncontrolled hypertension (HITS): cost and cost-effectiveness analysis of a randomised controlled trial. BMJ Open. 2013;3(5):e002681.PubMedPubMedCentralCrossRef
58.
go back to reference Rinfret S, Lussier MT, Peirce A, Duhamel F, Cossette S, Lalonde L, et al. The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care. Circ Cardiovasc Qual Outcomes. 2009;2(3):170–7.PubMedCrossRef Rinfret S, Lussier MT, Peirce A, Duhamel F, Cossette S, Lalonde L, et al. The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care. Circ Cardiovasc Qual Outcomes. 2009;2(3):170–7.PubMedCrossRef
59.
go back to reference Kario K, Morisawa Y, Sukonthasarn A, Turana Y, Chia YC, Park S, et al. COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network. J Clin Hypertens (Greenwich). 2020;22(7):1109–19.CrossRef Kario K, Morisawa Y, Sukonthasarn A, Turana Y, Chia YC, Park S, et al. COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network. J Clin Hypertens (Greenwich). 2020;22(7):1109–19.CrossRef
60.
go back to reference Niznik JD, He H, Kane-Gill SL. Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: a systematic review. Res Social Adm Pharm. 2018;14(8):707–17.PubMedCrossRef Niznik JD, He H, Kane-Gill SL. Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: a systematic review. Res Social Adm Pharm. 2018;14(8):707–17.PubMedCrossRef
61.
go back to reference Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med. 2017;14(9):e1002389.PubMedPubMedCentralCrossRef Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med. 2017;14(9):e1002389.PubMedPubMedCentralCrossRef
62.
go back to reference McLean G, Murray E, Band R, Saunderson K, Hanlon P, Little P, et al. Digital interventions to promote self-management in adults with hypertension: protocol for systematic review and meta-analysis. JMIR Res Protoc. 2015;4(4):e133.PubMedPubMedCentralCrossRef McLean G, Murray E, Band R, Saunderson K, Hanlon P, Little P, et al. Digital interventions to promote self-management in adults with hypertension: protocol for systematic review and meta-analysis. JMIR Res Protoc. 2015;4(4):e133.PubMedPubMedCentralCrossRef
63.
go back to reference Lu X, Yang H, Xia X, Lin J, Liu F, Gu D. Interactive mobile health intervention and blood pressure management in adults. Hypertension. 2019;74(3):697–704.PubMedCrossRef Lu X, Yang H, Xia X, Lin J, Liu F, Gu D. Interactive mobile health intervention and blood pressure management in adults. Hypertension. 2019;74(3):697–704.PubMedCrossRef
Metadata
Title
Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic
Authors
Barbara Citoni
Ilaria Figliuzzi
Vivianne Presta
Massimo Volpe
Giuliano Tocci
Publication date
01-01-2022
Publisher
Springer International Publishing
Published in
High Blood Pressure & Cardiovascular Prevention / Issue 1/2022
Print ISSN: 1120-9879
Electronic ISSN: 1179-1985
DOI
https://doi.org/10.1007/s40292-021-00492-4

Other articles of this Issue 1/2022

High Blood Pressure & Cardiovascular Prevention 1/2022 Go to the issue

Acknowledgement to Referees

Acknowledgement to Referees